New RNAi treatment targets eye inflammation

Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.
Source: Feed4

Leave a Reply

Your email address will not be published. Required fields are marked *